John Barrie Ward
Director/Board Member chez ADC Products (UK) Ltd.
Profil
John Barrie Ward is currently a Director at ADC Products (UK) Ltd.
and ADC Therapeutics (UK) Ltd.
He previously held positions as Chairman & Chief Executive Officer at Virus Research Institute, Inc., Chief Executive Officer at KuDOS Pharmaceuticals Ltd., Chairman at CellCentric Ltd.
(2012-2013), Chairman at ImmunoBiology Ltd., Non-Executive Chairman at London Genetics Ltd., Director at AVANT Immunotherapeutics, Inc., Non-Executive Director at Biotica Technology Ltd., Independent Non-Executive Director at Pharming Group NV (2007-2021), Director at Cancer Research Technology Ltd., Studies Director & Member-Microbiology Division at The National Institute For Medical Research, Non-Executive Director at BerGenBio ASA, Director-Microbiology Division at Glaxo Research Laboratories (1984-1994), Non-Executive Director at ADC Therapeutics SA, Director at Spirogen SARL, and Principal at AstraZeneca AB.
He obtained undergraduate and doctorate degrees from the University of Bath.
Postes actifs de John Barrie Ward
| Sociétés | Poste | Début |
|---|---|---|
ADC Products (UK) Ltd.
 ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom. | Director/Board Member | 23/06/2016 |
ADC Therapeutics (UK) Ltd.
 ADC Therapeutics (UK) Ltd. BiotechnologyHealth Technology Part of ADC Therapeutics SA, ADC Therapeutics (UK) Ltd. is a British company that provides research and experimental development in biotechnology. The private company is based in Reading, UK and was founded in 2014. | Director/Board Member | 12/03/2015 |
Anciens postes connus de John Barrie Ward
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMING GROUP N.V. | Director/Board Member | 19/05/2021 |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | Director/Board Member | 16/04/2007 |
KuDOS Pharmaceuticals Ltd.
 KuDOS Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KuDOS Pharmaceuticals Ltd. discovers and develops pharmaceutical products. Its products are used to treat DNA damage sensing, signaling, viral disease, ischaemia, and repair to address unmet medical needs in cancer treatment. The company was founded by Stephen Jackson on December 12, 1997 and is headquartered in Cambridge, UK. | Chief Executive Officer | 01/01/2006 |
Virus Research Institute, Inc.
 Virus Research Institute, Inc. BiotechnologyHealth Technology Part of Celldex Therapeutics, Inc., Virus Research Institute, Inc. develops systems for the delivery of vaccines. The private company is based in Cambridge, MA. | Chief Executive Officer | - |
| Glaxo Research Laboratories | Corporate Officer/Principal | - |
Formation de John Barrie Ward
| University of Bath | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PHARMING GROUP N.V. | Health Technology |
| BERGENBIO ASA | Health Technology |
| ADC THERAPEUTICS SA | Health Technology |
| Entreprise privées | 13 |
|---|---|
Virus Research Institute, Inc.
Virus Research Institute, Inc. BiotechnologyHealth Technology Part of Celldex Therapeutics, Inc., Virus Research Institute, Inc. develops systems for the delivery of vaccines. The private company is based in Cambridge, MA. | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | Health Technology |
Biotica Technology Ltd.
 Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
KuDOS Pharmaceuticals Ltd.
KuDOS Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KuDOS Pharmaceuticals Ltd. discovers and develops pharmaceutical products. Its products are used to treat DNA damage sensing, signaling, viral disease, ischaemia, and repair to address unmet medical needs in cancer treatment. The company was founded by Stephen Jackson on December 12, 1997 and is headquartered in Cambridge, UK. | Health Technology |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Health Technology |
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
ImmunoBiology Ltd.
 ImmunoBiology Ltd. BiotechnologyHealth Technology ImmunoBiology Ltd. develops next generation of vaccines for infectious diseases. It develops vaccines that protect against pathogens by mimicking the natural immune response to infection. The firm offers ImmBioVax and ImmunoBodies vaccines. The company was founded by Camilo Colaco in 1999 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
ADC Products (UK) Ltd.
ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom. | Health Services |
| London Genetics Ltd. | |
| Glaxo Research Laboratories | |
Spirogen SARL
 Spirogen SARL Pharmaceuticals: MajorHealth Technology Spirogen SARL is a Swiss company. 'The private company is based in Lausanne, Switzerland. The company was founded by Christopher John Martin. | Health Technology |
ADC Therapeutics (UK) Ltd.
ADC Therapeutics (UK) Ltd. BiotechnologyHealth Technology Part of ADC Therapeutics SA, ADC Therapeutics (UK) Ltd. is a British company that provides research and experimental development in biotechnology. The private company is based in Reading, UK and was founded in 2014. | Health Technology |
